Multiple Organ Dysfunction Syndrome
52 drugs12,371 FAERS reportsMedDRA PT
GET
/api/v1/reaction/multiple-organ-dysfunction-syndromeReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D009102
A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
Source: U.S. National Library of Medicine — MeSH (Multiple Organ Failure)
Drugs reporting Multiple Organ Dysfunction Syndrome (52)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Ammonium Chloride9641%
- 2Diethyltoluamide218%
- 3Sodium Citrate21716%
- 4Sodium Ferric Gluconate Complex23711%
- 5Anidulafungin17211%
- 6Defibrotide3439.7%
- 7Dobutamine4218.8%
- 8Natamycin338.7%
- 9Brincidofovir118.1%
- 10Potassium Chlorate667.5%
- 11Xylometazoline377.0%
- 12Mafenide26.5%
- 13Eravacycline146.4%
- 14Norepinephrine8436.0%
- 15Terlipressin175.9%
- 16Lanthanum Carbonate2665.3%
- 17Lanthanum2665.3%
- 18Peramivir85.2%
- 19Lifileucel125.0%
- 20Treosulfan1224.8%
- 21Cefiderocol144.6%
- 22Cidofovir624.5%
- 23Idarucizumab624.3%
- 24Meropenem1,2594.0%
- 25Clofarabine893.9%
- 26Ganciclovir4073.8%
- 27Sodium Nitrite23.7%
- 28Foscarnet1413.6%
- 29Basiliximab4103.6%
- 30Rasburicase783.3%
- 31Micafungin2723.3%
- 32Dalteparin3323.2%
- 33Amphotericin6073.0%
- 34Amphotericin B6073.0%
- 35Caspofungin1393.0%
- 36Thiotepa2672.9%
- 37Inotuzumab Ozogamicin812.8%
- 38Dopamine1062.8%
- 39Emapalumab52.7%
- 40Heparin3532.6%
- 41Angiotensin Ii72.5%
- 42Cisatracurium522.4%
- 43Ceftazidime1782.3%
- 44Piperacillin7262.2%
- 45Cefepime3472.2%
- 46Voriconazole6542.2%
- 47Tazobactam7352.2%
- 48Ceftriaxone8052.1%
- 49Thiosulfate112.1%
- 50Cefotaxime761.8%
- 51Remdesivir2311.8%
- 52Nitric Oxide711.6%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
Literature
Recent PubMed references pinned to Multiple Organ Failure as a MeSH major topic. About the reaction term itself — not about any specific drug.
- [Research progress on neutrophil gelatinase-associated lipocalin and sepsis-induced organ dysfunction].Zhonghua wei zhong bing ji jiu yi xue · 2026 · Deng P, Xu C, Wang Z, et al.PMID 42200250DOI 10.3760/cma.j.cn121430-20250723-00697
- Systemic inflammatory response drives post-cardiac arrest multi-organ injury via IL-17 signaling in murine and porcine models.Frontiers in immunology · 2026 · Yan Y, Chen T, Yuan A, et al.PMID 42136658DOI 10.3389/fimmu.2026.1837813
- Dose-dependent effects of methylene blue on hemodynamics, cytokines, oxidative stress, and organ dysfunction in a rat model of CLP-induced sepsis: An experimental study.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026 · Özcan Ö, Kara ŞŞ, Bal Özkaptan B, et al.PMID 42092307DOI 10.1016/j.biopha.2026.119469
- 10-epi-Protectin DX and Resolvin D5(n-3 DPA) Attenuate Multi-Organ Inflammatory Injury in an LPS-Induced Murine Endotoxemia Model.International journal of molecular sciences · 2026 · Kim S, Kim U, Kim N, et al.PMID 42074000DOI 10.3390/ijms27083356
- A Novel Therapeutic Strategy for Sepsis: The Multiorgan Protective Properties and Clinical Potential of Ulineastatin.Shock (Augusta, Ga.) · 2026 · Zhang H, Liang X, Liu XH, et al.PMID 42059826DOI 10.1097/SHK.0000000000002731
- [Application of a Sequential Blood Purification Approach in a Complex Critically Ill Patient].Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia · 2026 · Zanetti V, Cavagnaro S, Conti NE, et al.PMID 42037290DOI 10.69097/43-01-2026-12
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.